Annual report
4973.TEDINET S100O9RC
Period2021-04-01 → 2022-03-31
Filed2022-06-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 93
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥16.6bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥13.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.7bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥956m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥974m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥791m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥858m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥844m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥829m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥16.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥16.1bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥12.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.4bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥10.8bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥10.2bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.1bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2021-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2020-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.1bn | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥180m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥364m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥251m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥967m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥699m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥94m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥41m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥152m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥91m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥28m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥426m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥447m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥442m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥433m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥431m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥166.8 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.53 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.58 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.36 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.13 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥165.16 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥134.53 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥146.61 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥144.72 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥142.7 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥90 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,416.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,259.1 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,834 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,749.52 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,911.18 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.9% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.1% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.2% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,317,200 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,317,200 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,317,200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,317,200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,317,200 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 44 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 47 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 45 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 45 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 46 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,126
| Item | Context | Value | Unit |
|---|---|---|---|
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row21Member | Original text (Japanese)当社めっき薬品の取引があり、同社との良好な関係の維持、強化を図るため、継続して保有しています。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row21Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row22Member | Original text (Japanese)㈱みずほフィナンシャルグループ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row22Member | Original text (Japanese)当社の事業活動において助言をいただくなどの良好な関係の維持、強化を図るため、継続して保有しています。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row22Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row23Member | Ｉ－ＰＥＸ㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row23Member | Original text (Japanese)当社めっき薬品の取引があり、同社との良好な関係の維持、強化を図るため、継続して保有しています。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row23Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row24Member | Original text (Japanese)日本シイエムケイ㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row24Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row24Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row25Member | Original text (Japanese)大日本印刷㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row25Member | Original text (Japanese)当社めっき薬品の取引があり、同社との良好な関係の維持、強化を図るため、継続して保有しています。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row25Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row26Member | ＳＭＫ㈱ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row26Member | Original text (Japanese)当社めっき薬品の取引があり、同社との良好な関係の維持、強化を図るため、継続して保有しています。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row26Member | Original text (Japanese)無 | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYearDuration | Original text (Japanese)当社は子会社がありませんので、連結財務諸表は作成しておりません。 | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Statement of income (text) | CurrentYearDuration | Text · Plus | |
| Detailed schedule of manufacturing cost (text) | CurrentYearDuration | Text · Plus | |
| Statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes derivatives financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |